Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
2001 1
2003 1
2004 1
2006 1
2008 2
2009 4
2010 6
2011 4
2012 4
2013 9
2014 10
2015 13
2016 6
2017 4
2018 11
2019 11
2020 7
2021 3
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression.
Vanhersecke L, Brunet M, Guégan JP, Rey C, Bougouin A, Cousin S, Moulec SL, Besse B, Loriot Y, Larroquette M, Soubeyran I, Toulmonde M, Roubaud G, Pernot S, Cabart M, Chomy F, Lefevre C, Bourcier K, Kind M, Giglioli I, Sautès-Fridman C, Velasco V, Courgeon F, Oflazoglu E, Savina A, Marabelle A, Soria JC, Bellera C, Sofeu C, Bessede A, Fridman WH, Loarer FL, Italiano A. Vanhersecke L, et al. Among authors: bourcier k. Nat Cancer. 2021 Aug;2(8):794-802. doi: 10.1038/s43018-021-00232-6. Epub 2021 Aug 12. Nat Cancer. 2021. PMID: 35118423 Free PMC article.
Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial.
Cousin S, Cantarel C, Guegan JP, Mazard T, Gomez-Roca C, Metges JP, Bellera C, Adenis A, Korakis I, Poureau PG, Bourcier K, Toulmonde M, Kind M, Rey C, Auzanneau C, Bessede A, Soubeyran I, Italiano A. Cousin S, et al. Among authors: bourcier k. Eur J Cancer. 2022 Feb;162:161-169. doi: 10.1016/j.ejca.2021.11.012. Epub 2022 Jan 5. Eur J Cancer. 2022. PMID: 34998048 Clinical Trial.
Challenges and next steps in the advancement of immunotherapy: summary of the 2018 and 2020 National Cancer Institute workshops on cell-based immunotherapy for solid tumors.
Fogli LK, Aurigemma R, Sommers CL, Singh A, Bourcier K, Ernstoff MS; NCI Cell Therapy Workshop Committee. Fogli LK, et al. Among authors: bourcier k. J Immunother Cancer. 2021 Jul;9(7):e003048. doi: 10.1136/jitc-2021-003048. J Immunother Cancer. 2021. PMID: 34266886 Free PMC article.
Prospective evaluation of an anti-cancer drugs management programme in a dedicated oral therapy center (DICTO programme).
Deluche E, Darbas T, Bourcier K, Montangon L, Bayard G, Caille E, Querrioux J, Suchaud C, Zabaleta S, Chaput S, Le Brun-Ly V, Pestre J, Venat L, Thuillier F, Nevado E, Maillan G, Jost J, Leobon S, Tubiana-Mathieu N, Lavau-Denes S. Deluche E, et al. Among authors: bourcier k. Med Oncol. 2020 Jul 25;37(8):69. doi: 10.1007/s12032-020-01393-7. Med Oncol. 2020. PMID: 32712771 Free PMC article.
89 results